Tuberculosis Testing Market

SKU: DMMD2595 | Last Updated On: Oct 28 2022 | Available Formats

>Tuberculosis Testing Market is Expected to reach a high CAGR 6.0% By 2029:

Tuberculosis Testing Market is segmented By Test Type (Nuсlеіс Асіd Теѕtіng, Cytokine Detection Assay, Detection of Latent Infection, Сulturе Ваѕеd Теѕtѕ, Drug Ѕuѕсерtіbіlіtу Теѕtіng, others), By End-User (Hospital laboratories, Research laboratories, Clinics laboratories, Diagnostic center), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029

Tuberculosis Testing Market Size, Share Growth Insights

Tuberculosis Testing Market size was valued at US$ 1,337.10 million in 2021 and is estimated to reach US$ 2058.0 million by 2029, growing at a CAGR of 6.0% during the forecast period (2022-2029). Tuberculosis (TB) is a communicable disease that is a major cause of ill health, one of the top 10 causes of death worldwide, and the leading cause of death from a single infectious agent. It is caused by the bacillus Mycobacterium tuberculosis, which is spread when sick people with TB expel bacteria into the air, for example, by coughing. It typically affects the lungs (pulmonary TB) but can also affect other sites. About a quarter of the world’s population is infected with M. tuberculosis and thus at risk of developing TB disease. Tuberculosis testing can be defined as the most commonly used diagnostic tool for tuberculosis. With a timely diagnosis and treatment with first-line antibiotics for 6 months, most people who develop TB can be cured, and onward transmission of infection curtailed. The number of TB cases occurring each year can also be driven down by reducing the prevalence of health-related risk factors for TB by providing preventive treatment to people.

As per DataM Intelligence, Tuberculosis Testing Market study analysis offers an in-depth outlook on the market containing quantitative and qualitative data. It gives an outlook and forecast of the global market based on market segmentation. It also provides global Tuberculosis Testing Market size, and growth, along with the latest trends, opportunities, and forecast till 2029 for the global market with esteem to major countries such as the United States, Canada, Brazil, Germany, Italy, Spain, United Kingdom, Russia, European countries, United Arab Emirates, Saudi Arabia, South Africa, Japan, China, India, South Korea, Australia, and rest of the countries over the globe.

Among all regions, the North American region is expected to hold the largest share of the global market over the forecast period. Tuberculosis Testing Market in the United States and Canada produces the utmost share. Whereas the European Tuberculosis Testing Market is projected to continue its presence globally during the period of 2022- 2029.

Tuberculosis Testing Market  Scope

Metrics

Details

Market CAGR

6.0%

Segments Covered

By Test Type, By End-User, and By Region

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other vital insights.

Fastest Growing Region

Asia Pacific

Largest Market Share 

North America

To know more insights into the Market, Get Our Sample Brochure

Market Dynamics

The tuberculosis testing market is driven by the increasing burden of tuberculosis and multidrug-resistant tuberculosis, increasing government initiatives, and rising awareness in the emerging market.

The increasing burden of tuberculosis is expected to drive market growth.

The market is driven by the increasing number of coronavirus cases, increasing the number of tuberculosis patients.  According to the World Health Organization (WHO), in 2020, an estimated 10 million people fell ill with tuberculosis (TB) worldwide, 5.6 million men, 3.3 million women, and 1.1 million children, which is more than half of global TB deaths. Factors propelling the market's growth include the increasing burden of tuberculosis and multidrug-resistant tuberculosis, increasing R&D investments, intensive product pipelines, and increasing government initiatives in emerging markets. The landscape of TB diagnostics has changed dramatically during the past ten years. Moreover, in response to the WHO Global TB program, it has implemented a systematic and dynamic process used to evaluate technologies and develop policies, which has enhanced the market's growth.

The prevalence rate of tuberculosis is also increasing every year, along with the number of government awareness programs that influence people to opt for diagnostic tests (like radiographic tests), which are expected to drive the market during the forecast period. The market is also expected to witness growth as there is an opportunity for players in the market to accelerate their pipeline diagnostic products' market approval by spurring fundamental research in TB. Additionally, technological developments in genomics and proteomics can be leveraged by diagnostic providers to hasten product development in TB diagnostics.

The increasing screening rate in the high burden regions, affordability of diagnostics, advanced methodologies, faster clinical decisions, and reduction in mortality rate are the focal areas of development. Improved preventive and curative diagnosis rates are the results of these initiatives. This has led to a subsequent upsurge in demand for diagnostic tests and the TB diagnostics market. Furthermore, the government and independent healthcare organizations have undertaken initiatives to control this infectious disease's proliferation. Creating awareness about the importance of diagnosis is vital in increasing the screening and diagnosis rates, further helping the TB diagnostics market flourish. This factor is driving the growth of the market in the forecast period. For instance, the Revised National Tuberculosis Control Program (RNTCP) in India focuses on performing TB screening and providing greater access to treatment through free diagnosis & treatment programs. Besides, private-public partnerships under this program are boosting the diagnosis rate.

Population above the age of 60 is the target population for the TB diagnostics market as this demographic is susceptible to infectious diseases. The growing geriatric population base, as a result, is driving the growth of the market.

Market Growth

However, drug resistance in tuberculosis is one of the primary concerns for healthcare professionals as improper treatment due to wrong drug regimens and incorrect dosage forms leads to drug resistance in TB patients undergoing treatment, restraining the market's growth.

Industry Analysis

The global tuberculosis testing market provides in-depth analysis of the market based on various industry factors such as Porter’s Five Forces, Regulatory Analysis, Supply Chain Analysis, Pricing Analysis, Product Innovation, and Unmet Needs.

Segment Analysis

The test type segment is expected to hold the largest market share in the global Tuberculosis Testing market

The global tuberculosis testing market is segmented on test type by Cytokine Detection Assay, Nuсlеіс Асіd Теѕtіng, Detection of Latent Infection, Сulturе Ваѕеd Теѕtѕ, Drug Ѕuѕсерtіbіlіtу Теѕtіng, and Оthеrѕ. The Nuсlеіс Асіd Теѕtіng segment held the largest market share due to its use as a diagnostic tool for tuberculosis (TB) for many years, and which continues to be used. There are substantial advancements in the diagnosis of TB. Moreover, these tests have been commercially available in the United States for over two decades offer better accuracy than other microscopy tests, and even provide greater speed than culture-based tests. A nucleic acid test for tuberculosis (TB) is a molecular test used to detect the DNA (deoxyribonucleic acid) of the Mycobacterium tuberculosis complex (MTBC) in sputum or other respiratory samples. Because the amount of DNA in a sample is minimal, NAA testing includes a step that amplifies (or copies) the genetic material. Polymerase Chain Reaction (PCR) is a common form of nucleic acid test used in laboratory diagnosis. Drug Ѕuѕсерtіbіlіtу Теѕtіng is expected to have positive market growth because they are cost-efficient and easy to perform. The high-burden regions rely on these methodologies due to their financial and technical incapability to incorporate advanced technologies, thus contributing to their growth.

A Cytokine Detection Assay is usually employed to check for the specific cytokines being secreted. This is more a function of biochemistry research rather than a specific test for body functions. Cytokines and their receptors are under a great deal of research because of their role in disease control. It is worth noting that many cytokines have an opposing and sometimes complementary effect on each other; thereby, modulating the immune response's severity. Cytokine assays are used to identify which cytokines and their deficiencies are responsible for the cause of some autoimmune diseases.

A Detection of Latent Infection The goal of testing for LTBI is to identify individuals at increased risk for developing tuberculosis (TB) and, therefore, who would benefit from treatment of latent TB infection. Only those who would benefit from treatment should be tested, so a decision to test presupposes a decision to treat if the test is positive. This factor would drive the growth of the market in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global tuberculosis testing market

By region, the Tuberculosis Testing market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa. Asia-Pacific dominated the global tuberculosis testing market and is expected to grow at the highest CAGR during the forecast period. The growth of the market in the region is attributed to tuberculosis's high burden and the rapid proliferation of this disease. The increasing prevalence of TB in Japan helps in the TB diagnostics market. The high prevalence of TB creates an urgent demand for an effective and quick diagnosis of the disease. Besides, in countries such as India, according to the recent budget announcement, the Government of India aims to eliminate tuberculosis by 2025, which is expected to act as one of the major factors for the growth of the Asia-Pacific market forecast period.

Infectious and Endemic Disease Control in China, RNTCP in India, and the National TB program in Afghanistan are the few programs planned by local healthcare agencies to contain the incidence and ensure equitable access to diagnosis. As per the WHO, countries such as India, China, Afghanistan, and Indonesia are priority regions for controlling this communicable disease.

Competitive Landscape

The global tuberculosis testing market is highly competitive, with the presence of several international and local markets. Product diversification, revenue generation, and opportunities intensify the market competition. Thermo Fisher Scientific, Inc., Hologic Corporation, Abbott Laboratories, Alere, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche AG, bioMerieux SA, Sanofi, Cepheid, Hain Lifescience GmbH, are the leading market players with significant market share.

Global Tuberculosis Testing Market – Key Companies to Watch

Abbott Laboratories:

Overview: Abbott is an American multinational company that develops medical devices and healthcare products. It was founded in 1888 and is headquartered in Illinois, United States. Their products and services include medical devices, diagnostics, nutritional products, and branded generic medicines.

Product Portfolio:

The Abbott RealTime MTB assay is an in vitro polymerase chain reaction (PCR) assay for the qualitative detection of MTB complex DNA in smear-positive or smears negative specimens of sputum or bronchial alveolar lavage and N-acetyl-L-cysteine (NALC)-prepared sediments prepared from sputum and bronchial alveolar lavage collected from individuals suspected of having tuberculosis (TB).

Frequently Asked Questions

What is the Growth Rate of the Tuberculosis Testing Market?

Growing at a CAGR of 6.0% during the forecast period (2022-2029).

What Companies Are Included in the Tuberculosis Testing Market?

The Companies include Abbott Laboratories, Becton Dickinson and Business, F. Hoffmann- La Rocher AG, BioMerieux SA, Sanofi, Cepheid, and Hain Lifescience GmbH.

Trending Topics

Tuberculosis Drug Market

Tuberculosis – Pipeline Insight

India, Pakistan & Cambodia Tuberculosis Treatment Market

Brucellosis Vaccines Market

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

20% Discount Applied*



Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!

linkedinpinterest